A CGM-Based model for predicting hypoglycemia in type 2 diabetes patients with TIR in target

基于 CGM 的模型用于预测目标范围内血糖达标的 2 型糖尿病患者的低血糖发生情况

阅读:1

Abstract

AIM: This study aims to predict risk factors for hypoglycemia in patients with type 2 diabetes mellitus (T2DM) using continuous glucose monitoring (CGM) and with time in range (TIR) > 70%. METHODS: Data from 111 patients with T2DM who underwent CGM with TIR > 70% were analyzed. A hypoglycemia episode was defined as CGM-detected glucose < 3.9mmol/L sustained for at least 5 min. Logistic regression analysis was performed to examine the relationship between hypoglycemia and mean blood glucose (MBG), glycemic variability (GV) metrics [including mean amplitude of glucose excursion (MAGE), largest amplitude of glycemic excursion (LAGE), mean of daily difference (MODD), coefficient of variation (CV), standard deviation (SD)], and low blood glucose index (LBGI). A nomogram model was constructed, and its diagnostic performance was assessed. Data were bootstrapped 1000 times for internal validation, and a calibration curve was drawn to evaluate the model's predictive ability. Decision curve analysis was performed to assess its clinical usefulness. RESULTS: Among the 111 included patients, 53 experienced hypoglycemic event during wearing CGM (47.75%). GV metrics were higher in hypoglycemia group, while MBG was lower. The multivariable logistic regression analysis showed that the MBG, GV metrics, LBGI were independently associated with hypoglycemia. The receiver operating characteristics (ROC) analysis indicated that the area under the curve (AUC) for the MBG-SD-LBGI model was 0.93 (95% CI = 0.88-0.97). The calibration curve showed good consistency between the predicted and observed probabilities. Decision curve analysis demonstrated strong clinical applicability. CONCLUSION: This study demonstrates a significant correlation between CGM metrics and hypoglycemia in patients with T2DM who achieved TIR > 70%. These findings suggest that CGM metrics can predict the risk of hypoglycemia in T2DM patients with a TIR > 70%, and the nomogram developed from these metrics holds strong potential for clinical application.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。